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ABSTRACT
Cerium oxide nanoparticles have been widely used for various applications such as catalytic
converters for automobile exhaust, ultraviolet absorber, and electrolyte in fuel cells. Most
recently, cerium oxide nanoparticles (nanoceria) have been employed as potent free-radical
scavengers with neuroprotective, radioprotective, and anti-inflammatory properties. These
properties of cerium oxide nanoparticles can open new vistas in medicine and biotechnology.
The present study utilizes the water-based-wet-chemical method to synthesize biocompatible,
stable and highly monodisperse polymer coated cerium oxide nanoparticles. Polymer coated
cerium oxide nanoparticles possess all the characteristics of the uncoated cerium oxide
nanoparticles. These nanoparticles were found to be effective as pH-dependent antioxidant
giving cytoprotection to normal cell lines against hydrogen peroxide and nitric oxide radical but
not to cancer cells. Moreover, cerium oxide nanoparticle also exhibits unique oxidase-like
activity at acidic pH oxidizing a series of organic compound without the need of hydrogen
peroxide. Based on these results, we have designed an immunoassay in which folate-conjugated
cerium oxide nanoparticles provide dual functionality by binding to folate expressing cancer
cells and facilitating detection by catalytic oxidation of sensitive colorimetric substrates (dyes).
Finally, we have shown that the polymer coated cerium oxide nanoparticles shows distinct
toxicity depending upon their subcellular localization based on uptake studies using DiI loadedcerium oxide nanoparticles. In these results, we have found that cerium oxide nanoparticles
entrapped into lysosomes are more toxic as opposed to when they are localized in the cytoplasm.
Overall we propose that the polymer coated cerium oxide nanoparticles displays selective
antioxidant property, oxidase-like activity, and cytotoxicity to biological systems depending
upon its pH environment.
ii

ACKNOWLEDGMENTS
I wish to express my sincere gratitude towards my advisor Dr. J Manuel Perez, for his support,
guidance, thoughtful discussions and patience. Without his motivation and help, this research
work would not have been possible.
I am very grateful to Dr. Diego Diaz, Dr. Lei Zhai, Dr. Swadeshmukul Santra, and Dr. Ming Su
for serving on my thesis committee and their invaluable suggestions which made research a
really great experience.
I thank the Chemistry Department, the NanoScience Technology Center, the Materials
Characterizations Facility and the Army Edgewood Chemical and Biological Center for making
available the characterization facilities required for this research work. Also I would like to
acknowledge all of my colleagues and group members specially Charalambos Kaittanis,
Santimukul Santra, Oscar Santisteben for their cooperation and support. I would also like to
thank Sudip Nath for assistance during initial research projects. Special thanks to Vipra Dhir for
all her help. She stood by me, both at good and hard times. It is very hard to find people as great
as Vipra. Also, I would like to thank Suhasini Rayadurgam, Sejal Jagirdar, and Jignesh Vyas for
their support. I would like acknowledge Dr. Max Poole for all his motivation and assistance. I
am grateful to the NIH and UCF-NSTC for the financial support. Also, I wish to thank American
Association of Pharmaceutical Scientist and American Vacuum Society for recognizing my
research through Graduate Research Excellence Awards.
Words cannot express my deepest gratitude towards my parents and my brothers Ashish, Akash
and Abhishek for their limitless sacrifices towards what I am today. I would like to give the
fullest credit to my family members without whose love and support this thesis would never been
realized.

iii

TABLE OF CONTENTS
LIST OF FIGURES ..................................................................................................................... viii
LIST OF TABLES ........................................................................................................................ xv
LIST OF ABBREVIATIONS ...................................................................................................... xvi
CHAPTER 1 INTRODUCTION .................................................................................................... 1
1.1 Nanotechnology .................................................................................................................... 1
1.2 Cerium oxide: Background and Motivation .......................................................................... 2
1.3 Organization .......................................................................................................................... 4
CHAPTER 2: SYNTHESIS, CHARACTERIZATION AND ANTIOXIDANT ACTIVITY OF
DEXTRAN COATED CERIUM OXIDE NANOPARTICLES .................................................... 5
2.1 Introduction ........................................................................................................................... 5
2.2 Synthesis and characterization of dextran coated cerium oxide nanoparticles ..................... 5
2.3 Autocatalytic activity determination of dextran coated cerium oxide nanoparticles .......... 10
2.4 Determination of antioxidant or free radical scavenging activity of dextran coated cerium
oxide nanoparticles:................................................................................................................... 14
2.4.1 Chronic treatment studies: ............................................................................................ 14
2.4.2 Cell viability assays against Hydrogen peroxide induced oxidative stress: ................. 15
2.5 Experimental section: .......................................................................................................... 18
2.5.1 Synthesis and characterization of DNC:....................................................................... 18
2.5.2 Autocatalytic activity assay: ......................................................................................... 19
iv

2.5.3 Cell studies: .................................................................................................................. 20
2.6 Conclusion:.......................................................................................................................... 21
CHAPTER 3: STUDY OF pH-DEPENDENT BEHAVIOR OF POLYMER COATED CERIUM
OXIDE NANOPARTICLES, ITS OXIDASE LIKE ACTIVITY AND POTENTIAL
APPLICATION IN CELLULAR ELISA ..................................................................................... 23
3.1 Introduction: ........................................................................................................................ 23
3.2 Assessment of the pH dependent oxidase-like behavior of polymer coated cerium oxide
nanoparticles by oxidation of pH-sensitive colorimetric dyes .................................................. 24
3.3 Effect of size on the catalytic property of cerium oxide nanoparticles: .............................. 30
3.4 Determination of Steady-State kinetics of cerium oxide nanoparticles mediated oxidation
of dyes ....................................................................................................................................... 34
3.5 Oxidase like activity of cerium oxide nanoparticles and application in cellular ELISA .... 38
3.6 Experimental section: .......................................................................................................... 43
3.6.1 Synthesis of isPNC and isDNC .................................................................................... 43
3.6.2 Synthesis of swPNC and swDNC................................................................................. 43
3.6.3 Characterization ............................................................................................................ 43
3.6.4 Oxidation Studies and kinetic analysis ......................................................................... 44
3.6.5 Synthesis of folate-conjugated cerium oxide nanoparticles: ........................................ 44
3.6.6 Immunoassays: ............................................................................................................. 46
3.7 Conclusions: ........................................................................................................................ 47

v

CHAPTER 4: CELLULAR UPTAKE STUDIES USING FLUOSCENTLY LABLED CERIUM
OXIDE NANOPARTICLES HAVING DIFFERENT SURFACE CHARGE AND THEIR
CORRESPONDING CYTOTOXICITY ...................................................................................... 48
4.1 Introduction: ........................................................................................................................ 48
4.2 Synthesis and characterization of polymeric DiI labeled cerium oxide nanoparticles: ...... 50
4.3 Differential Cellular Interaction of Polymeric Cerium Oxide Nanoparticles with different
Surface Charge: ......................................................................................................................... 51
4.4 Mechanism of Cellular Uptake (Active Endocytic Process Blockage): ............................. 56
4.5 Intracellular Distribution of Polymeric Cerium Oxide Nanoparticles (Lysosomal Staining
or co-localization studies): ........................................................................................................ 58
4.6 Intracellular Distribution Dependent Cytotoxicity of Polymeric Cerium Oxide
Nanoparticles:............................................................................................................................ 60
4.7 Comparison with iron oxide nanoparticles: ........................................................................ 62
4.8 Experimental section: .......................................................................................................... 64
4.8.1 Synthesis of PAA-coated ceria ..................................................................................... 64
4.8.2 Amination of PAA-coated ceria ................................................................................... 65
4.8.3 DiI encapsulation in PAA-coated ceria and aminated- PAA-coated ceria ................... 65
4.8.4 Characterization ............................................................................................................ 65
4.8.5 Cell Studies ................................................................................................................... 66
4.8.6 Cellular Uptake of Nanoparticles ................................................................................. 66
4.8.7 Inhibition of Uptake or Inhibitors ................................................................................. 66
vi

4.8.8 Lysosome Labeling or Lysotracker Staining ................................................................ 67
4.8.9 Cell viability Assays ..................................................................................................... 67
4.9 Conclusions: ........................................................................................................................ 67
CHAPTER 5: CONCLUSIONS ................................................................................................... 72
REFERENCES ............................................................................................................................. 74

vii

LIST OF FIGURES

Figure 2-1. Schematic depicting the formation of stable cerium oxide nanoparticles.................... 7
Figure 2-2. Characterization of dextran-coated nanoceria. a) TEM image with corresponding
SAED pattern (inset). b) Representative HRTEM image of a single crystal. c) XRD image
showing the presence of (111), (220), (311), and (331) planes, typical of an fcc crystal. d) XPS
analysis showing the presence of both Ce+3 and Ce+4 in the nanoceria preparation. e) DLS
analysis showing a monodisperse nanoparticle preparation with an average hydrodynamic
diameter of 10 nm. f) Photograph showing a 1) 10.0, 2) 20.0, 3) 30.0, and 4) 40.0mM aqueous
solutions of dextran-coated nanoparticle. ....................................................................................... 8
Figure 2-3. Confirmation of the presence of dextran on nanoceria. Time-dependent DLS analysis
of a DNC preparation upon incubation with Concanavalin A, showing an increase in the average
hydrodynamic diameter due to concavalin-A-induced clustering of the dextran coating on DNC 9
Figure 2-4. Autocatalytic activity of dextran-coated nanoceria at physiological and acidic pH.
Autocatalytic activity of dextran-coated nanoceria at physiological and acidic pH. A) Reversible
color changes in a solution of dextran-coated nanoceria at pH 7.4, upon addition of hydrogen
peroxide. B) Irreversible color changes in a solution of dextran-coated nanoceria at pH 4.0, upon
addition of hydrogen peroxide. C) Transmittance spectra showing reversible autocatalytic
behavior for DNC upon incubation with H2O2 at pH 7.4 (black: control, before addition of H2O2;
red: immediately after addition of H2O2; green: 24 h, blue: 3 days, pink: 7 days). D)
Transmittance spectra of nanoceria showing irreversible autocatalytic behavior for DNC upon
viii

incubation with H2O2 at pH 4.0. (black: control, before addition of H2O2; red: immediately after
addition of H2O2; green: 24 h, blue: 3 days). ................................................................................ 12
Figure 2-5. Hypothesized pH-dependent behavior of nanoceria. A facile water based synthetic
technique for monodispersed and highly crystalline dextran-coated nanoceria (DNC) has been
reported. The particles exhibit an effective antioxidant property for several living cell lines,
which is found to be active at neutral pH and inactive at acidic microenvironment. ................... 13
Figure 2-6. Chronic exposure experiment. Multiple treatments of DNC to cardiomyocytes.
Multiple treatments of DNC to cardiomyocytes (d,e,f) does not affect the morphology and
growth patterns of the cells in culture, as compared to non-treated control cells (a,b,c), even after
the cells were harvested and replated at a lower density and allow to grow for a week (f). These
results confirm the biocompatibility and nontoxicity of both preparations. ................................. 15
Figure 2-7. Effect of dextran nanoceria on normal and cancer cell line against H2O2-induced
toxicity. DNC protects normal cardiomyocytes (a) and human dermal fibroblasts (b) against
hydrogen peroxide induced oxidative stress. In contrast, no protection is observed in lung
carcinoma cells (c) and breast carcinoma (d) treated with DNC. All data points represent the
average of three measurements with standard errors ranging between 1.0 to 2.0% (too small to
graph). ........................................................................................................................................... 17
Figure 2-8. Dextran nanoceria protects cardiomyocytes from nitroxyl radical (●NO) induced. .. 18
Figure 3-1 Photographs shows production of oxidation product at pH 4.0 upon addition of
nanoceria to TMB, AzBTS (a), and no color reaction at pH 7.0 (b). ........................................... 25

ix

Figure 3-2 Graph showing the characteristics UV-visible peak for oxidation product of TMB (a)
and AzBTS (b). ............................................................................................................................. 26
Figure 3-3 Nanoceria mediated oxidation of TMB (a) and AzBTS (b) is pH dependent. ............ 27
Figure 3-4 Nanoceria promoted oxidation of DOPA. Orange color aminochrome (a) and UVprofile of oxidized DOPA to aminochrome (b). ........................................................................... 29
Figure 3-5 Hydrodynamic diameter distributions. (a) in-situ dextran coated nanoceria (isDNC),
(b) stepwise dextran coated nanoceria (swDNC), (c) in-situ polyacrylic acid coated nanoceria
(isPNC), and (d) stepwise polyacrylic acid coated nanoceria (swPNC). ...................................... 32
Figure 3-6 Nanoceria-promoted oxidation of TMB (a) and AzBTS (b) is size dependent. ......... 33
Figure 3-7 Steady kinetics of nanoceria mediated oxidation of TMB at various pH, (a) pH 4.0,
(b) pH 5.0, (c) pH 6.0, and (d) pH 7.0. ......................................................................................... 36
Figure 3-8 Steady kinetics of nanoceria mediated oxidation of TMB usinng different size
nanoceria preparation, (a) in-situ polyacrylic acid coated nanoceria (isPNC), (b) stepwise
polyacrylic acid coated nanoceria (swPNC), (c) in-situ dextran coated nanoceria (isDNC), and
(d) stepwise dextran coated nanoceria (swDNC).......................................................................... 37
Figure 3-9 Comparison of traditional ELISA (a) and nanoceria-based ELISA (b). In traditional 39
Figure 3-10 Synthesis of folate-conjugated cerium oxide nanoparticles. ..................................... 40
Figure 3-11 Fluorescence emission profile of folate-conjugated cerium oxide nanoparticles.
Graph exhibits the characteristics peaks for both cerium oxide nanoparticles and folic acid in

x

folate conjugated particles confirming the that surface of nanoceria is functionalized with folic
acid. ............................................................................................................................................... 40
Figure 3-12 Nanoceria-mediated ELISA detection of folate receptor expressing cells. Folate–
nanoceria associating with A-549 cells, which overexpress the folate receptor, effectively
oxidizes TMB................................................................................................................................ 42
Figure 3-13 Nanoceria-based immunoassay is sensitive to the number of folate-positive cells
(folate-receptor-expressing cells A-549). ..................................................................................... 42
Figure 4-1 Schematic representation of the synthesis of surface functionalized cerium oxide
nanoparticles and dye encapsulation. Cerium oxide nanoparticles with different surface charge
were synthesized using water based wet chemical method. Carbodiimide chemistry was
employed to modify the surface of the carboxylated nanoceria. DiI was encapsulated using
modified solvent diffusion method ............................................................................................... 53
Figure 4-2 Characterization of cerium oxide nanoparticles. (a) Zeta potential measurement of
cerium oxide nanoparticle with different surface functional group (negative, neutral and
positive), (b) FT-IR spectrum confirming the amination of PAA-coated cerium oxide
nanoparticles, characteristics peak are shown (c) Nanocrystal core size calculated from the TEM
images, and (d) Fluorescence emission spectra of the DiI encapsulated nanoceria and that of free
dye in solution. .............................................................................................................................. 54
Figure 4-3: Real time live cell confocal imaging: Cationic polymeric nanoceria is being uptaken
in real time by lung carcinoma which shows the internalization is not due the artifacts introduced
by fixation procedure. (Similar results were obtained with anionic polymeric, neutral nanoceria,
and also with cardiac myocytes) ................................................................................................... 55
xi

Figure 4-4. Uptake of cerium oxide nanoparticles. Confocal microscopy show that aminated
nanoceria (+ve) is being uptaken by both cell lines lung carcinoma and cardiac myocytes while
carboxylated nanoceria (-ve) are being uptaken only by lung carcinoma cell lines. Positive
nanoparticles internalize more and seem to be localized into particular cell organelle such as
lysosomes. Negative nanoparticles shows less internalization but surprisingly mostly into
lysosmes. While neutral particles exhibit more diffuse kind of internalization and all over the
cytoplasm. ..................................................................................................................................... 55
Figure 4-5. Uptake studies where active internalization processes were blocked (Determination
of internalization mechanism). No internalization of aminated or carboxylated nanoparticle is
seen in either of the cell line in presence of inhibitors, 2-deoxyglucose and sodium-azide which
blocks active internalization. Similarly, internalization of nanoparticles is abrogated at 4 ○C.
These results suggest that the uptake of nanoparticles is mediated by endocytosis since endocytic
processes are inhibited by both inhibitors and at 4 ○C .................................................................. 57
Figure 4-6. Nanoparticles cell localization, lysosomal staining (Lung carcinoma). Upon
internalization nanoparticles fluorescently labeled DiI were found in colocalized into lysosomes.
Most of the internalized nanoparticles were co-localized with lysotracker (overlay). Dextran
nanoceria exhibits less co-localization with lysotracker. .............................................................. 59
Figure 4-7. Nanoparticles cell localization, lysosomal staining (Cardiac myocytes). Aminated
nanoceria (red dye) were found to co-localize less with lysotracker in normal cell line compare to
lung carcinoma. Also, dextran-nanoceria shows even less lysotracker co-localization compare to
aminated nanoceria. However most the nanoparticles in both cases were found in the cytoplasm
....................................................................................................................................................... 60

xii

Figure 4-8. Cytotoxicity of cerium oxide nanoparticles. Graph shows that aminated nanoparticles
are more cytotoxic to both cell lines while carboxylated nanoparticles are cytotoxic to only lung
carcinoma not to cardiac myocytes. However, dextran nanoceria don’t show any toxicity to
either of cell lines .......................................................................................................................... 61
Figure 4-9. Cytotoxicity of cerium oxide nanoparticles in presence of inhibitors showing no
toxicity. ......................................................................................................................................... 62
Figure 4-10. Uptake of polyacrylic acid coated iron oxide nanoparticles. Confocal showed that
only aminated-PAA iron oxide nanoparticles were uptaken by lung carcinoma and cardiac
myocytes. ...................................................................................................................................... 63
Figure 4-11. Cytotoxicity of Iron oxide nanoparticles demonstrating that polymeric iron oxide
nanoparticles are not toxic to any of the cancer or normal cell lines. ........................................... 64
Figure 4-12. Schematic representation of nanoparticles cell internalization, localization and
hypothesized mechanism for their toxicity. As shown in schematic aminated nanoceria are found
more internalized and entrapped mostly in lyosome in lung carcinoma. pH of microenvironment
of lung carcinoma and lyosome is acidic enough for nanoceria to exhibit oxidase like activity.
This might be the reason why aminated nanoceria are more cyototoxic compare to carboxylated
which are less toxic to lung carcinoma. However, aminated nanoceria are also toxic to cardiac
myocytes since they are found both in lysosomes and cytoplasm in cardiac myocytes.
Carboxylated nanoparticles don’t show any internalization in cardiac myocytes hence any
toxicity. Dextran nanoceria shows very diffuse kind of internalization and are less confined to
lysosomes which do not alter nanoceria property and hence dextran nanoparticles not toxic to
either of cell lines. ......................................................................................................................... 71
xiii

xiv

LIST OF TABLES
Table 3.1 Nanoceria’s oxidase-like kinetics are both pH and size dependent .............................. 35

xv

LIST OF ABBREVIATIONS
AzBTS

2,2-azino-bis(3-ethylbenzothizoline-6-sulfonic acid)

CDI

1,1’-carbonyldiimidazole

CeO

Cerium oxide

Con A

Concanavalin A

DAPI

4',6-diamidino-2-phenylindole

DLS

Dynamic light scattering

DMF

Dimethyl formamide

DMSO

Dimethylsulfoxide

DNC

Dextran coated-nanoceria

DOPA

Dopamine

EDA

Ethylene diamine

EDC

1-ethyl-3-(3-dimethylaminopropyl) carbodiimide)

ELISA

Enzyme linked immune sorbent assay

FBS

Fetal bovine serum

FT-IR

Fourier transform-infra red spectroscopy

GSNO

S-nitrosoglutathione

HDF

Human dermal fibroblasts

HO

Hydrogen peroxide

HRP

Horseradish peroxidase

HRTEM

High Resolution Transmission Electron Microscopy

2

2

2

xvi

ICP-MS

Inductively coupled plasma mass spectroscopy

isDNC

In-situ dextran coated nanoceria

isPNC

In-situ polyacrylic acid coated nanoceria

MES

2-(N-morpholino)ethanesulfonic acid

MTT

(3-(4,5-dimethyl-thiazol-2-yl)-2,5 diphenyltetrazolium bromide)

NHS

N-hydroxy succinamide

PBS

Phosphate buffer saline

PNC

Polyacrylic acid coated nanoceria

ROS

Reactive oxygen species

SAED

Selected area diffraction pattern

SEM

Scanning electron microscopy

SOD

Superoxide dismutase

swDNC

Stepwise dextran coated nanoceria

swPNC

Stepwise polyacrylic acid coated nanoceria

TEM

Transmission electron microscopy

TMB

3,3,5,5’-tetramethyl benzidine

UV

Ultraviolet

XPS

X-ray Photoelectron Spectroscopy

XRD

X-ray Diffraction

ZP

Zeta Potential

xvii

CHAPTER 1 INTRODUCTION
1.1 Nanotechnology
Most people accept that nanotechnology was first introduced at a lecture entitled “There is plenty
of room at the bottom”, delivered in 1959 by Noble laureate Richard Feyman at the California
Institute of Technology’s American Physical Society Meeting.1 It has not been until the last 10
years, that nanotechnology has seen revolutionary growth in different areas such as chemistry,
physics, and biology. This growth and development has brought the Feyman’s dreams of playing
with the individual atoms and molecules at scale of nanometers i.e. “Nanoscience” to reality2,3
Nanotechnology is an emerging and enabling technology carried out at the nanometer scale (1nm
is 10-9m). It involves the manufacturing of chemical and biological systems at the nanoscale
level. The impressive and enhanced physiochemical properties are noticed when the materials
are manufactured and engineered at the nanoscale. Although, the potential of nanotechnology has
been greatly applauded, novel properties of nanomaterials raise concerns about adverse effects
on biological systems and environmental impact.
Surface area plays a key role in determining the properties of a nanomaterial. At the nanoscale,
surface area increases exposing more atoms on the surface. These changes in dimensions not
only increase the surface area but also significantly alter the other properties such as catalytic or
chemical reactivity, electrical conductivity, optical properties and so on. At nanoscale, the
surface energy of nanomaterials and their corresponding surface morphology such as surface
defects also changes significantly, therefore contributing to alterations in their fundamental
properties and reactive nature.
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Although significant advances have been made during last years, nanotechnology is still at its
infant stage. It needs further exploration as it is just carrying forward from the bench scale to the
industrial or real applications. Future developments in nanotechnology promises great
advancement in various areas ranging from electronic, materials, medicine, diagnostics,
biotechnology and environment etc. Discovery of novel materials, techniques and phenomena
are expected through innovations at the nanoscale. Furthermore, developments of new theoretical
and experimental processes may lead to well advanced nanosystems or nanostructures with new
unique property which may further improve human life.

1.2 Cerium oxide: Background and Motivation
Cerium is the second element in the lanthanides series in the periodic table which are known as
the rare earth element. Most of the rare earth metals exist in their trivalent state; however cerium
occurs in both trivalent (+3) as well as tetravalent (+4) state and it has the unique ability to
switch readily between these two states.4-6 Cerium oxide is widely used for various applications
such in catalytic converters, solid oxide fuel cells7, and as an excellent oxygen buffers.8 Because
of its ability to alter its oxidation state readily (Ce+3 and Ce+4), cerium oxide creates oxygen
vacancies or surface defects either by loss of electron or oxygen.4,5 These alteration in surface
property or crystal structure depend upon various factors such oxygen partial pressure,
temperature, and doping.4,5,9
The chemical reactivity of cerium oxide nanoparticles (nanoceria) is for the most part similar to
the reactivity of the bulk cerium oxide. However, the increased numbers of oxygen vacancy
defects on the cerium oxide nanoparticles will improve the performance and the efficiency. For
example, the antioxidant or free radical scavenging activity of cerium oxide nanoparticles and its
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radioprotective capacity to normal cell line against the radiation has received much attention.10
Although, cerium oxide nanoparticles has been seen as a impressive antioxidant nanoparticles for
therapeutic applications, very little consideration has been given to the fact that one needs to
synthesize biocompatible cerium oxide nanoparticles with better stability and biocompatibility in
physiological solutions. Here we report the synthesis of biocompatible polymer coated cerium
oxide nanoparticles and their characterization. Furthermore, this polymer coated cerium oxide
nanoparticles were evaluated for their free radical scavenging properties. Our original intent was
to create a highly biocompatible polymer coated cerium oxide with all characteristics property of
cerium oxide nanoparticles. The increased water solubility allowed for studies at different pH.
Based on results we hypothesized that the polymer coated cerium oxide nanoparticles exhibits
pH-dependent antioxidant property.
Polymer coated cerium oxide nanoparticles displays antioxidant property at physiological pH
while at low pH loses its antioxidant activity. Here we propose cerium oxide nanoparticles
behave as an oxidant. These studies include the oxidation of pH-sensitive colorimetric dyes in
the range of pH 4.0 and higher pH. Results showed that cerium oxide nanoparticles were able to
oxidize these dyes at acidic pH 4.0 while no reaction was seen at pH 7.0. Next, when compared
with the other systems such as HRP/H2O2, cerium oxide nanoparticles mediated oxidation of
these dyes does not require hydrogen peroxide. Based upon these findings, the oxidase-like
enzymatic behavior of polymer coated cerium oxide nanoparticles was studied. We developed
the cerium-oxide-nanoparticles-based-cellular-ELISA for monitoring the folate receptor on the
lung carcinoma cell line, utilizing the oxidase like activity of cerium oxide nanoaprticles.
Next in order to understand the cellular interactions of cerium oxide nanoparticles, cellular
uptake and their corresponding toxicity studies were carried out. For this purpose cerium oxide
3

nanoparticle with different surface charge was synthesized. It was observed that cerium oxide
nanoparticles with neutral surface charge were not toxic to either one of the cancer or normal
cells. In contrast, positive nanoparticles exhibited significant toxicity to both cell lines, and
negative nanoparticles were toxic to only cancer but not normal. Moreover different kind
internalization was seen for both the cell lines with different surface charge particles.
The primary objective of this work is to synthesize biocompatible cerium oxide nanoparticles
having antioxidant property; study their pH-dependent behavior in aqueous systems and cellular
uptake since it could have important applications in the design of improved therapeutics.

1.3 Organization
The primary focus of this dissertation/study is on the synthesis of biocompatible nanoceria and
their application in biomedical fields. The dissertation can be divided into three major parts
namely synthesis of nanoceria, its oxidase like behavior, and cytotoxicity studies. Chapter 2 shed
light into the wet chemical method for the synthesis of biocompatible, stable and monodisperse
polymer coated cerium oxide nanoparticles. Chapter 3 provides facts about the pH-dependent
oxidase-like behavior and potential of nanoceria as a single reagent for cellular ELISA. Chapter
4 is focused on the cellular interactions, internalization, subcellular localization and toxicity of
nanoceria with different cell lines.
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CHAPTER 2: SYNTHESIS, CHARACTERIZATION AND ANTIOXIDANT
ACTIVITY OF DEXTRAN COATED CERIUM OXIDE NANOPARTICLES

2.1 Introduction
Cerium oxide nanoparticles have been used as a potent free-radical scavengers with
neuroprotective,11 radioprotective,10 and anti-inflammatory properties.12 Cerium oxide
nanoparticles also have the unique property of being regenerative or autocatalytic.13 These
results point to the possibility of engineering cerium oxide nanoparticles with selective
antioxidant properties that promote cell survival under conditions of oxidative stress. However,
most of these studies have been done with nanoparticles with poor water solubility or
synthesized by procedures involving toxic solvents, therefore hindering their potential clinical
use. Here we proposed a facile synthesis of monodisperse, water-soluble, and highly crystalline
dextran-coated cerium oxide nanoparticles. We found that dextran coated cerium oxide
nanoparticles show a unique pH-dependent antioxidant activity that could have important
applications in the design of improved therapeutics and in tailoring its antioxidant properties.

2.2 Synthesis and characterization of dextran coated cerium oxide nanoparticles
Our synthetic procedure involves the alkaline-based precipitation of cerium oxide (Ce2O3:CeO2)
from a solution containing cerium salt and dextran. Briefly, an aqueous solution of cerium nitrate
and dextran was added to an ammonia solution under continuous stirring. Upon formation of the
cerium oxide nanocrystals, molecules of dextran coat the nanoparticles’ surface, preventing

5

further growth and resulting in dextran-coated cerium oxide nanoparticles or nanoceria (DNC)
(Figure 2.1). The dextran-coated cerium oxide nanoparticle preparation is stable in phosphatebuffered saline (PBS) at concentrations of 40mM or higher for months. Dextran-coated cerium
oxide nanoparticles demonstrates good water stability even after several heating cycles (70–80
○

C) with no sedimentation upon centrifugation at 8000 rpm for 30 min. These characteristics

make our water based synthetic method advantageous over organic-solvent based
preparations,14–20 which are prone to aggregation when suspended in aqueous media.
Next, synthesized nanoparticles were characterized for surface morphology, shape, size,
crystallinity, oxidation state and polymer coating. Transmission electron microscopy (TEM)
analysis of dextran-coated cerium oxide nanoparticle shows the presence of discrete nanocrystals
with an average size of 4 nm (Figure 2.2a), while high-resolution TEM (HRTEM) shows a
crystalline nanoceria core (Figure 2.2b). A face-centered-cubic (fcc) core was identified by
selected area electron diffraction (SAED; Figure 1a, inset) with lattice planes in good agreement
with those obtained from an X-ray diffraction (XRD) pattern (Figure 2.2c).18 X-ray
photoelectron spectroscopy (XPS) data indicates the presence of a mixed valence state in
dextran-coated cerium oxide nanoparticle, giving the corresponding binding energy peaks for
Ce+3 and Ce+4 (Figure 2.2d), and suggesting that the dextran coating does not affect its mixed
valence state. In addition, dynamic light scattering (DLS) studies revealed a monodisperse size
distribution for dextran-coated cerium oxide nanoparticle with an average diameter of 14nm
(Figure 2.2e). Most importantly, the dextran-coated cerium oxide nanoparticle preparation can be
concentrated in PBS by ultrafiltration, without precipitation of the nanoparticles (Figure 2.2f),
and no difference in crystallinity, monodispersity, or mixed valency was found in dextran-coated
cerium oxide nanoparticle preparations stored at 4 ○C for over six months.
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In addition, experiments with concanavalin A (Con-A), a protein with high affinity towards
carbohydrates,21 were performed to further demonstrate the association of dextran with
nanoceria. We hypothesized that a ConA-induced self-assembly of the nanoparticles would result
if the nanoparticles are coated with dextran.22 As expected, DLS studies of dextran-coated
cerium oxide nanoparticle after addition of ConA (10 mgmL-1, final concentration) showed a
time-dependent aggregation of the nanoparticle (Figure 2.3). Taken together, these results
demonstrate the robustness of the dextran nanoceria preparations under physiologically relevant
conditions and that the dextran is associated with the nanoparticles.

Figure 2-1. Schematic depicting the formation of stable cerium oxide nanoparticles.
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Figure 2-2. Characterization of dextran-coated nanoceria. a) TEM image with corresponding SAED pattern (inset). b) Representative
HRTEM image of a single crystal. c) XRD image showing the presence of (111), (220), (311), and (331) planes, typical of an fcc
crystal. d) XPS analysis showing the presence of both Ce+3 and Ce+4 in the nanoceria preparation. e) DLS analysis showing a
monodisperse nanoparticle preparation with an average hydrodynamic diameter of 10 nm. f) Photograph showing a 1) 10.0, 2) 20.0, 3)
30.0, and 4) 40.0mM aqueous solutions of dextran-coated nanoparticle.
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Figure 2-3. Confirmation of the presence of dextran on nanoceria. Time-dependent DLS analysis
of a DNC preparation upon incubation with Concanavalin A, showing an increase in the average
hydrodynamic diameter due to concavalin-A-induced clustering of the dextran coating on DNC.
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2.3 Autocatalytic activity determination of dextran coated cerium oxide nanoparticles
One of the most interesting properties of nanoceria is its autocatalytic behavior.13 The ability of
these nanoparticles to reversibly switch from Ce+3 to Ce+4 is a key factor for their catalytic and
biological applications as antioxidants. For these reason, we first tested whether the dextran
coating compromised the nanoceria’s autocatalytic behavior. In these experiments, a solution of
dextran-coated cerium oxide nanoaprtilces (2.54mM) in PBS, pH 7.4, was incubated with 0.2 M
hydrogen peroxide (H2O2) as an oxidizer. Upon addition, a rapid color change, from yellow to
orange (Figure 2.4a), was observed, corresponding to a red shift in UV/Vis transmittance studies
(Figure 2.4c), red curve, compared to a control sample (Figure 2.4c), black curve. This change in
color is due to an increase in the ratio of Ce+4 to Ce+3 in the nanoceria core.13 During the
following 10 days, as the H2O2 decomposed from the nanoparticle suspension, the observed
orange color started to disappear and the solution returned to its original yellow color (Figure
2.4a). Correspondingly, a gradual shift of the transmittance curve to its original control value
was observed (Figure 2.4c), green, blue, and pink curves, respectively, demonstrating the
reversibility of the system under normal physiological conditions. Subsequent addition of H2O2
brought the color of the solution back to orange, which again started to disappear within the next
ten days (Figure 2.4a). This reversible behavior under physiological conditions is essential for
the antioxidant properties of nanoceria and its potential medical applications. Our results show
that the dextran coating does not affect the autocatalytic properties of nanoceria, as hydrogen
peroxide and peroxyl radicals can diffuse through the hydrophilic dextran coating and oxidize
Ce+3 to Ce+4. Similar results were obtained at basic pH 8 and 9; however, intriguing results were
obtained at acidic pH. Results show that at pH 4.0, dextran-coated cerium oxide nanoaprtilces
does not exhibit a significant red shift upon addition of H2O2, even though the color of the
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solution has turned slightly orange (Figure 2.4b and 2.4d). Surprisingly, after 24 hours, the
solution turned completely clear and a significantly large blue shift was observed in the
transmittance curve (Figure 2.4d), green curve. After ten days, the solution remained clear and
the addition of more H2O2 did not bring either the color of the solution back to orange or have
any effect on the transmittance curve. Furthermore, once the pH of dextran nanoceria preparation
was lowered to 4.0, its autocatalytic activity could not be reversed even upon raising the pH to
7.4, showing irreversibility at low pH. However, dextran-coated cerium oxide nanoparticles at
pH 7.4 was able to recover (regenerate) and come back to its initial amount of Ce+3 and Ce+4,
while the preparation at pH 4.0 remained the non-reversible at low pH. The mechanism for the
nonreversible, low-pH poisoning of dextran nanoceria is not well understood at this time. It has
been proposed that the antioxidant properties of nanoceria are due to the presence of mixed
valence states (Ce+3/Ce+4) on the nanoparticles’ surface that allow for the scavenging of free
radicals.13 During the scavenging process, Ce+3 ions are converted to Ce+4. The system is
regenerated via a series of surface chemical reactions between ions in solution (such as H+) and
the Ce+4 ions on the nanoparticle surface, where they are converted back to Ce+3, and therefore
allows for the scavenging of more free radicals. We hypothesize that the low-pH environment
interferes with the cyclical regenerative or autocatalytic nature of dextran-coated cerium oxide
nanoaprtilces due to the high concentration of protons (H+) at low pH, and therefore inhibit the
ability of nanoceria to scavenge more free radicals (Figure 2.5). This effect renders dextran
nanoceria as an inefficient antioxidant at low pH.
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Figure 2-4. Autocatalytic activity of dextran-coated nanoceria at physiological and acidic pH.
Autocatalytic activity of dextran-coated nanoceria at physiological and acidic pH. A) Reversible
color changes in a solution of dextran-coated nanoceria at pH 7.4, upon addition of hydrogen
peroxide. B) Irreversible color changes in a solution of dextran-coated nanoceria at pH 4.0, upon
addition of hydrogen peroxide. C) Transmittance spectra showing reversible autocatalytic
behavior for DNC upon incubation with H2O2 at pH 7.4 (black: control, before addition of H2O2;
red: immediately after addition of H2O2; green: 24 h, blue: 3 days, pink: 7 days). D)
Transmittance spectra of nanoceria showing irreversible autocatalytic behavior for DNC upon
incubation with H2O2 at pH 4.0. (black: control, before addition of H2O2; red: immediately after
addition of H2O2; green: 24 h, blue: 3 days).
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Figure 2-5. Hypothesized pH-dependent behavior of nanoceria. A facile water based synthetic
technique for monodispersed and highly crystalline dextran-coated nanoceria (DNC) has been
reported. The particles exhibit an effective antioxidant property for several living cell lines,
which is found to be active at neutral pH and inactive in acidic microenvironment.
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2.4 Determination of antioxidant or free radical scavenging activity of dextran coated
cerium oxide nanoparticles:
2.4.1 Chronic treatment studies:
The excellent water stability and autocatalytic properties of dextran coated cerium oxide
nanoparticles at physiological pH motivated us to perform cell studies. Multiple treatments
(treatment at every 48 hours) and prolonged incubation of normal cardiomyocytes with dextran
coated cerium oxide nanoparticles (1.0mM) at intervals of 48 h over a period of two weeks
resulted in no significant changes in the growth pattern and morphology of the cells, as compared
to control cells (Figures 2.6). More importantly, when the treated cells were harvested and
replated in the presence of additional dextran coated cerium oxide nanoparticles, the cells
proliferated similar to the control cells. These results indicate that the dextran nanoceria
preparation does not alter cellular physiology even after chronic exposure, since no changes in
morphology and proliferation of the cells were observed.
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Figure 2-6. Chronic exposure experiment. Multiple treatments of DNC to cardiomyocytes.
Multiple treatment of DNC to cardiomyocytes (d,e,f) does not affect the morphology and growth
patterns of the cells in culture, as compared to non-treated control cells (a,b,c), even after the
cells were harvested and replated at a lower density and allow to grow for a week (f). These
results confirm the biocompatibility and nontoxicity of both preparations.

2.4.2 Cell viability assays against Hydrogen peroxide induced oxidative stress:
Next, we investigated if DNC would protect normal cells against oxidative damage. In these
experiments, we exposed cardiomyocytes (Figure 2.7a) to high levels of H2O2 (0.2 M), and
monitored cell viability. As expected, when cells were exposed to H2O2, most of them died. In
contrast, when cells were pre-incubated with DNC before H2O2 incubation, no significant
changes in cell viability were observed as compared to untreated cells or cells treated with
nanoceria alone. Similar results were observed using a non-transformed human dermal fibroblast
15

(HDF) cell line Figure 2.7b. The observed nonreversible poisoning of dextran nanoceria at pH
4.0 could have important implications in cancer therapy. It is well known that most tumors have
acidic microenvironments due to high rates of glycolysis and lactic acid production, known as
the Warburg effect.23,24 Since generation of oxygen radicals (oxidative stress) occurs in both
tumor and healthy tissue during radiotherapy, DNC could facilitate pH-dependent preferential
protection of healthy tissue. We hypothesized that upon treatment with dextran nanoceria, cancer
cells would not be protected against H2O2-induced oxidative stress, due to their acidic
microenvironment. Here we suggest a possible role of the acidic tumor microenvironment, which
might contribute to the low-pH inhibition of nanoceria’s protective activity. To this end, we
treated lung (A-549) and breast cancer (BT-474) cells with DNC before administering H2O2 (0.2
M), and as expected no protection against oxidative damage was observed (Figure 2.7c and
2.7d). A-549 and BT-474 cancer cell lines have been reported to have upregulated glycolitic
activity and production of lactic acid, which results in an acidic microenvironment.25,26 As lung
and breast tumors are among the most prevalent and aggressive carcinomas, requiring extensive
radiotherapy and chemotherapy, DNC can provide long-term cytoprotection to nontransformed
surrounding cells, minimizing adverse side effects. Furthermore, dextran nanoceria provides
similar protection against other biologically relevant radicals, such as nitroxyl (NO.) (Figure 2.8).
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Figure 2-7. Effect of dextran nanoceria on normal and cancer cell line against H2O2-induced
toxicity. DNC protects normal cardiomyocytes (a) and human dermal fibroblasts (b) against
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hydrogen peroxide induced oxidative stress. In contrast, no protection is observed in lung
carcinoma cells (c) and breast carcinoma (d) treated with DNC. All data points represent the
average of three measurements with standard errors ranging between 1.0 to 2.0% (too small to
graph).
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Figure 2-8. Dextran nanoceria protects cardiomyocytes from nitroxyl radical (●NO) induced.

2.5 Experimental section:
2.5.1 Synthesis and characterization of DNC:
A solution containing 5.0 mL of 1.0 M cerium (III) nitrate (Aldrich, 99%) and 10.0 mL of 1.0 M
dextran T-10 (Amersham Bioscience) was added dropwise to a 30.0 mL ammonium hydroxide
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solution (Sigma Aldrich, 30%) and stirred for 24 h at 25 ○C. The color of the solution changed
from light yellow to dark brown, indicating the formation of stabilized dextran-coated ceria
nanoparticles. Afterwards, the solution was centrifuged at 4000 rpm for two 30 min cycles to
settle any debris and large agglomerates. Finally, the centrifuged solution was purified from free
dextran and concentrated using an Amicon cell (YM 30 K; Millipore Inc.) and stored at 4 ○C.
The concentration of cerium ion present in the nanoparticle preparation was determined by
inductively coupled plasma mass spectroscopy (ICP-MS) using an acid digestion technique at
Army Edgewood Chemical and Biological Center. TEM was performed by mounting a drop of
DNC on a holey carbon coated copper 400-mesh grid (2SPI, USA). Images were taken in a FEI
TECNAI F30 microscope operating at 300 kV. A Rigaku D/MAX XRD instrument with CuKa1
radiation was used for XRD analysis and measurements were recorded at a scan rate of 0.25
degree minS1. XPS was performed in a Physical Electronics 5400 ESCA spectrometer with a
base pressure of 109 Torr and MgKa X-ray radiation at a power of 200 W. Dynamic light
scattering (DLS) studies were performed by analyzing dilute solutions of DNC preparation using
a PDDLS/Cool Batch 40T, PD2000 DDLS. UV/Vis spectroscopic measurements were
performed using solutions of DNC in a Varian Cary 300 Bio UV/Vis spectrometer. Fluorescence
spectroscopy studies were done using a Nanolog HORIBA JOBIN YVON spectrometer. FT-IR
experiments were performed in a Perkin Elmer Spectrum 100 FT-IR spectrometer using samples
spotted on plastic cover slips.

2.5.2 Autocatalytic activity assay:
The autocatalytic activity was assessed by treating a 2.54 mM solution of DNC with 0.2 M of
H2O2 solution (Acros, 30%). The percentage transmittance was then monitored upon addition of
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hydrogen peroxide at 0 h, 1 day, 3 days, 7 days, and 10 days. As a control, a solution of
nanoparticles without hydrogen peroxide was used.

2.5.3 Cell studies:
Cardiomyocytes (H9c2), human dermal fibroblasts (BJ), lung cancer (A-549) and breast cancer
cells (BT-474) were obtained from ATCC, USA. Cardiomyocytes and human dermal fibroblasts
cells were grown in Eagle’s Minimal Essential medium supplemented with fetal bovine serum
(10%), sodium pyruvate, Lglutamine, penicillin, streptomycin, amphotericin B, and nonessential
amino acids. Lung-cancer cells were grown in Kaighn’s modification of Ham’s F12 medium
(F12K) supplemented with fetal bovine serum, L-glutamine, streptomycin, amphotericin B, and
sodium bicarbonate. Breast-cancer cells were grown in modified Dulbecco’s medium
supplemented with fetal bovine serum (10%), L-glutamine, streptomycin, penicillin, and
amphotericin B. All cell lines were maintained at 37 ○C, 5% CO2 in a humidified incubator.

Chronic exposure experiments:
Cardiomyocytes were seeded into 6-well plates at 50000 cells per well. After 24 h, the cells were
treated with DNC (1.0mM) and incubated for 48 h. The medium was then removed, the cells
were washed with PBS buffer, and again treated with the same concentration of DNC. After cells
were confluent they were harvested and replated into new flask. A similar procedure was
repeated for a period of two weeks.

Evaluation of DNC protection against H2O2-induced cytotoxicity:
Cells were seeded in 96-well plates at a density of 3000 cells per well and incubated with DNC
(1 mM) and then with hydrogen peroxide (0.2 M) for 2 h. Then, 0.5 mM of MTT (3-(4,520

dimethylthiazol- 2-yl)-2,5-diphenyltetrazolium bromide) (Sigma-Aldrich) was added followed
by incubation for 24 h. After 24 h, the resulting crystals were dissolved in 20 mL of isopropyl
alcohol and the absorbance at 570 nm was recorded using a plate reader (Bio-TEK, Synergy HT
Multidetection Microplate reader). These experiments were performed in triplicate.

Evaluation of DNC protection against nitric oxide-induced cytotoxicity:
Cells were seeded in 96-well plates at a density of 3000 cells per well and incubated with DNC
(1.0mM) and then with a 500 mM solution of S-nitrosoglutathione (GSNO; Sigma). The cells
were then incubated for 24 h. Next, 0.5mM of MTT was added, followed by incubation for 24 h.
Afterwards, the resulting crystals were dissolved in 20 mL of isopropyl alcohol and the
absorbance at 570 nm was recorded using a plate reader (Bio-TEK, Synergy HT Multidetection
Microplate reader). These experiments were performed in triplicate.

2.6 Conclusion:
In summary, these results show that our biocompatible dextran nanoceria exhibit excellent, pHdependent antioxidant properties for improved cancer therapeutics, as they provide
cytoprotection from free radicals to normal cells but not to cancer cells, which are typically in an
acidic environment. Dextran-coated iron oxide nanoparticles have been successfully developed
to exhibit enhanced biocompatibility and used as long circulating MRI contrast agents.27-32
Therefore, the adoption of the dextran nanoceria in animal and potentially human clinical studies
is possible. Taken together, our results support the imminent potential use of DNC as smart, pH-

21

dependent therapeutic agents and devices that selectively protect healthy tissue from free
radicals, which might be elevated during chronic inflammation or upon radio or chemotherapy.
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CHAPTER 3: STUDY OF pH-DEPENDENT BEHAVIOR OF POLYMER
COATED CERIUM OXIDE NANOPARTICLES, ITS OXIDASE LIKE
ACTIVITY AND POTENTIAL APPLICATION IN CELLULAR ELISA

3.1 Introduction:
Unique catalytic activities have been reported for nanoscale materials in recent years.17 These
size-dependent properties, which are often absent in the bulk materials, are the basis for the
design of novel catalysts with multiple applications in energy storage, chemical synthesis, and
biomedical applications.18-20,32-39 In previous chapters, we discussed that cerium oxide
nanoparticles (nanoceria) possess antioxidant activity at physiological pH values. Furthermore,
the synthesis of biocompatible dextran-coated cerium oxide nanoparticles and its enhanced
stability in aqueous solution has been recently reported.39
Nanoceria has pH-dependent antioxidant activity which are enhanced at physiological pH and
lost at acidic pH. Therefore we asked the question; if cerium oxide nanoparticles behave as an
oxidant at low pH. Herein, we report that nanoceria has an intrinsic oxidase-like activity at acidic
pH values, as it can quickly oxidize a series of organic substrates without any oxidizing agent
(e.g. hydrogen peroxide). The observed activity is not only pH-dependent but is also dependent
on the size of the cerium oxide nanoparticles as well as the thickness of the polymer coating. On
the basis of these findings, we have designed an immunoassay in which folate-conjugated cerium
oxide nanoparticles provide dual functionality by binding to folate expressing cancer cells and
facilitating detection by catalytic oxidation of sensitive colorimetric substrates (dyes). The
unique pH-dependent oxidase-like activity of cerium oxide nanoparticles in aqueous media
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makes them a powerful tool for a wide range of potential applications in biotechnology and
environmental chemistry.

3.2 Assessment of the pH dependent oxidase-like behavior of polymer coated cerium oxide
nanoparticles by oxidation of pH-sensitive colorimetric dyes
In these studies, we first investigated if a dextran coated cerium oxide nanoparticles preparation39
could facilitate the oxidation of a series of organic dyes at low pH values. In these experiments,
we selected 3,3’,5,5’-tetramethylbenzidine (TMB) and 2,2-azinobis(3-ethylbenzothizoline-6sulfonic acid) (AzBTS), which upon oxidation develop either a blue (TMB) or green (AzBTS)
color in aqueous solution.40,41 These dyes are typically used as horseradish peroxidase (HRP)
substrates in various bioassays, and most recently they have been used to demonstrate the
peroxidase-like activity of iron oxide nanoparticles.42 However, in these peroxidase-catalyzed
reactions, hydrogen peroxide (H2O2) is required as the electron acceptor or oxidizing agent. In
contrast, we have found that dextran coated cerium oxide nanoparticles catalyzes the fast
oxidation (within minutes) of both TMB and AzBTS in the absence of hydrogen peroxide, as
judged by the appearance of the characteristic color upon addition of the dyes to citrate-buffered
solutions (pH 4.0) of the nanoparticles (Figure 3.1a) and by the corresponding UV/Vis spectrum
(Figure 3.2a and Figure 3.2b). Meanwhile, at pH 7.0, no significant oxidation of TMB or AzBTS
was observed, even in the presence of hydrogen peroxide or upon overnight incubation, as
judged by the absence of color development upon addition of nanoceria at this pH value (Figure
3.1b).
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a)

b)

Figure 3-1 Photographs shows production of oxidation product at pH 4.0 upon addition of
nanoceria to TMB, AzBTS (a), and no color reaction at pH 7.0 (b).
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a)

b)

Figure 3-2 Graph showing the characteristics UV-visible peak for oxidation product of TMB (a)
and AzBTS (b).
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Furthermore, pH-dependent studies of the DNC-catalyzed oxidation of TMB or AzBTS show
that as the pH value of the buffered solution increases from pH 4.0 to 7.0, the ability of DNC to
oxidize the dye decreases (Figure 3.3a and 3.3b). These results suggest that dextran coated
cerium oxide nanoparticles behaves as an oxidation catalyst in a pH-dependent manner and
performs optimally at acidic pH values.
a)

b)

Figure 3-3 Nanoceria mediated oxidation of TMB (a) and AzBTS (b) is pH dependent.
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To further verify the ability of cerium oxide nanoparticles to behave as an oxidation
nanocatalyst, we chose dopamine (DOPA), a catecholamine difficult to oxidize at low pH
values.43 Results showed that dextran coated cerium oxide nanoparticles facilitated the oxidation
of DOPA in citrate buffer (pH 4.0) within minutes, producing the characteristic orange color
corresponding to aminochrome, one of the major oxidation products of DOPA (Figure 3.4a). The
formation of aminochrome by dextran coated nanoceria was confirmed by UV/Vis studies,
which show the appearance of the characteristic band at 475 nm (Figure 3.4b). However, in the
absence of DNC, no apparent oxidation of DOPA occurs at pH 4.0, even after days of
incubation. This result is in contrast to that for DOPA solutions in water or citrate buffer pH 7.0,
in which DOPA slowly autoxidizes, developing the characteristic reddish-brown color after
overnight incubation. Taken together, our results indicate that DNC is able to catalyze the
oxidation of various organic molecules at acidic pH values.
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a)

Citrate buffer
pH 4.0

b)

Figure 3-4 Nanoceria promoted oxidation of DOPA. Orange color aminochrome (a) and UVprofile of oxidized DOPA to aminochrome (b).
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3.3 Effect of size on the catalytic property of cerium oxide nanoparticles:
It has been well established that the catalytic properties of nanomaterials often depend upon the
size of the nanocrystal.44 However, studies on the effect of the thickness of a polymer coating
surrounding the nanoparticles are less common. This motivated us to study whether the
nanoceria catalyzed oxidation of these dyes is also dependent on nanoparticle size and on the
thickness of the polymer coating. Our previously reported dextran-coated nanoceria preparation
was synthesized by an in-situ procedure,39 in which the dextran (10 kDa) is present in solution at
the time of the initial formation of the cerium oxide nanocrystals. Under these conditions, the
polymer influences both the nucleation and the growth of the initial nanocrystal, resulting in
nanoparticles with a small nanocrystal core surrounded by a thin polymeric coating. In the case
of dextran coated cerium oxide nanoparticles, we have obtained nanoparticles with a cerium
oxide core of 4 nm surrounded by a thin coating of dextran for a total nanoparticle size
(hydrodynamic diameter) of 14 nm. Meanwhile, a stepwise procedure in which the polymer is
added at a specific time after initial formation of the nanocrystals can be adopted for the
synthesis of nanoceria. This method has been reported for the synthesis of polymer-coated iron
oxide nanoparticles and yielded nanoparticles with a thicker polymer coating than those from the
in-situ process.45 Furthermore, slightly larger nanocrystal cores are also obtained using this
method. Therefore, to study the effect of the polymeric coating thickness on the catalytic activity
of nanoceria, we synthesized dextran coated cerium oxide nanoparticles using a stepwise
method. In this method, the dextran polymer was added 60 seconds after initial formation of the
nanocrystals, to yield a stepwise dextran coated cerium oxide nanoparticle (swDNC)
nanoparticle preparation with an average hydrodynamic diameter of 100 nm, approximately ten
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times bigger than the dextran coated cerium oxide nanoparticles obtained with the in-situ method
(isDNC). Moreover, another set of polymer-coated ceria nanoparticles was synthesized using
poly(acrylic acid) (1.8 kDa). The use of a polymer with a smaller molecular weight in the
synthesis of polymer-coated nanoceria is advantageous, because it allows the formation of
nanoparticles with an even thinner coating than those obtained with dextran (10 kDa) using
either the in-situ or the stepwise method. Dynamic light scattering experiments show that for the
in situ nanoceria preparations coated with poly(acrylic acid) (isPNC), the average hydrodynamic
diameter of the nanoparticles was 5 nm; whereas for the stepwise preparation (swPNC), a value
of 12 nm was obtained Figure 3.5a-d. As expected, smaller nanoparticles with a thinner polymer
coating were obtained using the 1.8 kDa poly(acrylic acid) polymer.
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Figure 3-5 Hydrodynamic diameter distributions. (a) in-situ dextran coated nanoceria (isDNC),
(b) stepwise dextran coated nanoceria (swDNC), (c) in-situ polyacrylic acid coated nanoceria
(isPNC), and (d) stepwise polyacrylic acid coated nanoceria (swPNC).
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Next, we used these preparations of nanoceria to perform various kinetic studies and to assess the
effect of the coating thickness and nanoparticle size on the catalytic activity of nanoceria. Results
show that nanoceria’s ability to oxidize TMB varies with nanoparticle size in the order isPNC (5
nm)>swPNC (12 nm)>isDNC (14 nm)>swDNC (100 nm). Interestingly, the nanoparticles with a
thin poly-(acrylic acid) coating (isPNC) have a higher catalytic activity than those with a thicker
dextran coating (swDNC) (Figure 3.6a). This result might be attributed to the fact that nanoceria
with a thin and permeable poly(acrylic acid) coating can facilitate the transfer of molecules to
and from the nanoceria core surface faster than a thicker coating. Similar experiments were
performed with AzBTS, which shows similar behavior to TMB (Figure 3.6b).
a)

b)

Figure 3-6 Nanoceria-promoted oxidation of TMB (a) and AzBTS (b) is size dependent.

33

3.4 Determination of Steady-State kinetics of cerium oxide nanoparticles mediated
oxidation of dyes
In order to understand the oxidase-like behavior of cerium oxide nanoparticles, we determined
the steady-state kinetic parameters for the nanoceria-catalyzed oxidation of TMB. Typical
Michaelis–Menten curves were obtained for both PNC and DNC (Figures 3.7a-d) and (Figure
3.8a-d). Results show that as the hydrodynamic diameter of the nanoparticles increases, lower
values for the Michaelis constant Km and reaction rate Vmax are obtained (Table 3.1a). Similar
results were observed with AzBTS. The fact that the nanoceria preparation with the smallest
hydrodynamic diameter and thinnest coating (isPNC) displays the fastest kinetics (contrary to
swDNC) suggests that the thickness of the polymer coating plays a key role in the rate of
oxidation of the substrate. Furthermore, kinetic studies of nanoceria (isPNC) at various pH
values indicate faster kinetics at acidic pH values (Km=3.8, Vmax=0.7) and much slower
kinetics at neutral pH values (Km=1.3, Vmax=0.1) (Table 3.1b), as expected. These results
contrast with those obtained using the enzyme HRP or iron oxide nanoparticles, for which slower
kinetics are reported even in the presence of hydrogen peroxide. Better values were observed
with the cerium oxide nanoparticles when evaluated against the HRP/H2O2 system. 42
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Table 3.1 Nanoceria’s oxidase-like kinetics are both size (a) and pH (b) dependent.

a)

b)
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Figure 3-7 Steady state kinetics of nanoceria mediated oxidation of TMB at various pH, (a) pH
4.0, (b) pH 5.0, (c) pH 6.0, and (d) pH 7.0.

36

Figure 3-8 Steady state kinetics of nanoceria mediated oxidation of TMB usinng different size
nanoceria preparation, (a) in-situ polyacrylic acid coated nanoceria (isPNC), (b) stepwise
polyacrylic acid coated nanoceria (swPNC), (c) in-situ dextran coated nanoceria (isDNC), and
(d) stepwise dextran coated nanoceria (swDNC).

.
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3.5 Oxidase like activity of cerium oxide nanoparticles and application in cellular ELISA
The enzyme horseradish peroxidase (HRP) has been widely used in biotechnology, particularly
in ELISA for the detection of biomarkers and targets using substrate such as TMB and AzBTS
which produce characteristics color signal upon oxidation easily detected by spectrophotometric
methods. In traditional ELISA, an HRP-labeled secondary antibody is utilized to assess the
binding of a specific primary antibody to a particular target or surface receptor (Figure 3.9a).
This binding event is assessed by the ability of HRP to oxidize a chromogenic substrate such as
TMB in the presence of hydrogen peroxide. In traditional ELISA, the high rate of negative
results is mainly attributed to 1) the instability of the antibodies that, when denatured, do not
bind effectively to their target, 2) the instability of HRP that, when denatured, loses its
peroxidase activity, and 3) the instability of hydrogen peroxide which, upon prolonged storage,
decomposes and losses its ability to oxidize the substrate TMB in the presence of HRP. Since
nanoceria has the intrinsic ability to oxidize chromogenic dyes without the need of hydrogen
peroxide, we hypothesized that a nanoceria-based detection system could be approach would be
more robust than current HRP-based assays, as no hydrogen peroxide would be needed (Figure
3.8b). The oxidase-like activity of the nanoceria, by itself, should facilitate the oxidation and
corresponding color development. Using this assay, we can perform an immunoassay and
identify the presence and concentration of a target faster and cheaper than using traditional
ELISA. For this purpose, nanoceria coated with poly(acrylic acid) (isPNC) was conjugated to
folic acid using click chemistry (Figure 3.10), and conjugation was confirmed by presence of
characteristics emission peak for folic acid (Figure 3.11).46-49
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Figure 3-9 Comparison of traditional ELISA (a) and nanoceria-based ELISA (b). In traditional
ELISA, an HRP antibody is utilized as secondary antibody that, upon hydrogen peroxide
treatment, facilitates the oxidation of TMB, resulting in color development. In nanoceria based
ELISA, the oxidase-like activity of nanoceria facilitates the direct oxidation of TMB without the
need of HRP or hydrogen peroxide.
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Figure 3-10 Synthesis of folate-conjugated cerium oxide nanoparticles.

Figure 3-11 Fluorescence emission profile of folate-conjugated cerium oxide nanoparticles.
Graph exhibits the characteristics peaks for both cerium oxide nanoparticles and folic acid in
folate conjugated particles confirming the that surface of nanoceria is functionalized with folic
acid.

40

We used the folic acid because it is the ligand to folate receptor, which is over expressed in many
tumors and cancer cell lines.50,51 We hypothesized that a nanoceria conjugate with folic acid
instead of an antifolate receptor antibody will make a more robust nanoprobe for our
immunoassay. Experiments were performed using the lung cancer cell line (A-549), which
overexpresses the folate receptor.50,51 In control experiments, cardiac myocytes (H9c2) that do
not overexpress the folate receptor were used.52 In our first set of experiments, either A-549 or
H9c2 cells (6000 cells) were incubated with an increasing amount of folate–cerium oxide
nanoparticles in a 96-well plate for three hours and subsequently incubated with TMB (0.04 mm)
for 30 minutes; product formation was monitored at 652 nm using a microtiter plate reader. As
expected, a folate–nanoceria-dependent binding was observed for the lung carcinoma cell line
(A-549) compared to cardiac myocytes (H9c2), as judged by an increase in absorbance at 652
nm with increasing amount of folate–nanoceria (Figure 3.12). In another set of experiments, an
increasing number of folate-positive lung carcinoma cells (1500 to 6000 cells) were treated with
a constant amount of folate–ceria (5.0 mm). Results show an increase in the formation of TMB
oxidation product (652 nm absorbance) with increasing number of A549 cells (Figure 3.13). This
result was expected, as an increasing number of A549 cells translate into an increasing number
of surface folate receptors available for binding to the folate–ceria nanoparticles. These results
demonstrate the utility of cerium oxide nanoparticles as a detection tool, which arises from their
dual functionality. Nanoceria-based assays outperform traditional sandwich ELISA, which
requires hydrogen peroxide and an additional step to introduce an antibody carrying horseradish
peroxidase (HRP antibody) to allow detection.
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Figure 3-12 Nanoceria-mediated ELISA detection of folate receptor expressing cells. Folate–
nanoceria associating with A-549 cells, which overexpress the folate receptor, effectively
oxidizes TMB.

Figure 3-13 Nanoceria-based immunoassay is sensitive to the number of folate-positive cells
(folate-receptor-expressing cells A-549).
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3.6 Experimental section:
3.6.1 Synthesis of isPNC and isDNC
A solution containing 1M cerium (III) nitrate (Aldrich, 99%) solution (2.17g in 5.0 mL of water)
was mixed separately with 0.5 M solution of polyacrylic acid (PAA) (Sigma) or 1.0M dextran
(Sigma). Under continuous stirring, mixture was added to 30.0 mL ammonium hydroxide (Sigma
Aldrich, 30%) solution. Afterwards the mixture was stirred continuously for 24 h, At this point
the solution has changed from a light yellow to a deep brown color indicating the formation of
stabilized dextran and PAA coated-nanoceria. The preparation was then centrifuged at 4000 rpm
for two 30 minute cycles to settle down any debris and large agglomerates. The supernatant
solution was then purified from free PAA or dextran and concentrated using 30K Amicon cell
(Millipore Inc.).

3.6.2 Synthesis of swPNC and swDNC
For stepwise synthesis, a solution containing 1M cerium (III) nitrate (2.17 g in 5.0 mL of water)
was added continuous stirring to 30.0 mL ammonium hydroxide solution. Then, after one minute
0.5 M solution of PAA or 1.0 M dextran solution was added and allowed to stir for 3 h.
Purification and subsequent step were the same as in-situ method.

3.6.3 Characterization
Dynamic light scattering (DLS) studies were performed by analyzing dilute solutions of
nanoceria preparation using a PDDLS/Cool Batch 40T, PD2000 DDLS. UV-visible
spectroscopic measurements were done using solutions of nanoceria in a Varian Cary 300 Bio
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UV- visible spectrometer. FT-IR experiments were performed using vacuum dried samples of
nanoceria and spectra were recorded on Perkin Elmer Spectrum 100 FT-IR spectrometer.

3.6.4 Oxidation Studies and kinetic analysis
For oxidation studies, tetramethyl benzidine (TMB), 2,2-azinobis-(3-ethylbenzothizoline-6sulfonic acid (AzBTS) and dopamine (DOPA) were purchased from Sigma, USA. Steady-state
kinetic assays were carried out in 96 well plate using nanoceria (5.0 µM) at room temperature
with TMB and AzBTS in citrate buffer of pH 4.0. Reactions were monitored at 652 nm for TMB
and 405 nm for AzBTS in time scan mode using a Bio- TEK, Synergy HT Multidetection
Microplate reader. Color reactions were observed immediate upon addition of nanoceria to
substrate (TMB or AzBTS). To study the steady-state mechanism of the reaction, further
experiments were carried out using above conditions with varying concentrations of TMB or
AzBTS while nanoceria concentration was kept constant (5.0 µM). The kinetic parameters were
calculated based on Vmax is maximal velocity, [S] concentration of substrate and Km Michaelis
constant. In addition to above studies, simple UV profile of all three dyes were done to confirm
the type of oxidation product.

3.6.5 Synthesis of folate-conjugated cerium oxide nanoparticles:

Synthesis of propargylated cerium oxide nanoparticles:
The carboxylated cerium oxide nanoparticles (0.005 mg of ceria) were taken in an eppendorf
tube containing 2.0 mL of MES buffer (pH = 6.0), to this were added EDC (12.3 mg, 10 mmol)
and NHS (7.5 mg, 10 mmol) and stirred for 3 minutes. To the resulting reaction mixture,
propargyl amine (3.6 mg, 10 mmol) in 0.25 mL of DMF was added and incubated at room
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temperature for 4 h. The final reaction mixture was purified by dialysis using 6-8 K molecular
weight cut off dialysis bag, against deionized water and phosphate buffered saline (PBS)
solution.
Synthesis of Aminopropylazide:
Chloropropyl amine (2.0 g, 21.5 mmol) and sodium azide (4.19 g, 64.5 mmol) were taken in a 50
mL round bottom flask containing 25 mL of distilled water and heated at 75 oC for 18 h. The
reaction mixture was concentrated via a rotavapor using high vacuum, and 1.2 g of KOH was
added to it and then extracted by using diethyl ether. Subsequently, the reaction mixture was
dried over anhydrous sodium sulphate and concentrated. Then, the mixture was purified through
flash column chromatography using 4% ethyl acetate in petroleum ether as an eluent, in order to
obtain the pure aminopropylazide.
Yield: 1.45 g (68%). 1H NMR (300 MHz, CDCl3, δ ppm): 1.25 (bs, 2H), 1.82 (m, 2H), 2.81 (t,
2H), 3.36 (t, 2H). IR (CHCl3): 3305, 2942, 2087, 1665, 1434, 1372, 1258, 1241, 1076, 1026,
818, 761 cm-1.
Synthesis of azide-functionalized folic acid:
1,1’-carbonyldiimidazole (CDI) (9.0 mg, 0.054 mmol) was taken in an eppendorf tube containing
folic acid (20.0 mg, 0.045 mmol) in dry DMF (1 mL) and incubated for 2 h at 35 oC. To this
solution we added aminopropylazide (5.0 mg, 0.049 mmol) in dry DMF (75 µL) and incubated it
for 30 h at room temperature. The reaction mixture was then cetrifuged and washed to remove
excess starting materials. Finally, we dissolved the azide-functionalized folic acid in 1 mL of
DMF. The presence of a band at 2091 cm-1 in the IR spectrum and a UV absorbance at 353 nm
confirmed the formation of azide-functionalized folic acid.
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Synthesis of folate functionalized cerium oxide nanoparticles (Click chemistry):
The propargylated cerium oxide nanoparticles (0.013 g, 3 x 10-3 mmol) in bicarbonate buffer (pH
= 8.5) were taken to an eppendorf containing catalytic amount of CuI (0.05 µg, 3 x 10-10 mmol)
in 125 µL of bicarbonate buffer, mixed for 25 seconds. To this was solution azide-functionalized
folic acid (0.002 g, 4 x 10-2 mmol) in DMSO was added and the reaction was incubated at room
temperature for 12 h. The final reaction mixture was purified by dialysis using 6-8 K molecular
weight cut off dialysis bag, against deionized water and phosphate buffered saline (PBS)
solution. The purified functional cerium oxide nanoparticles were stored in refrigerator for
further characterization.

3.6.6 Immunoassays:
Cardiomyocytes (H9c2) and lung cancer (A-549) were obtained from ATCC, USA.
Cardiomyocytes cells were grown in Eagle’s Minimal Essential medium supplemented with fetal
bovine serum (10%), sodium pyruvate, L-glutamine, penicillin, streptomycin, amphotericin B,
and nonessential amino acids. Lung-cancer cells were grown in Kaighn’s modification of Ham’s
F12 medium (F12K) supplemented with fetal bovine serum, L-glutamine, streptomycin,
amphotericin B, and sodium bicarbonate. All cell lines were maintained at 37 ºC, 5% CO2 in a
humidified incubator. Cells were plated in 96 well plate at density of 6000 cells per well and
after 24 h incubation treated with different concentration of folate-nanoceria particles (0.5 μM to
5.0 μM). Particles were allowed to incubate for 3 h. Afterwards cells were washed with PBS
buffer and 50 μL of buffer was added to the plate. Afterwards, cells were treated with 50 μL of
TMB (0.04 mM) and allowed to develop the blue color. Then blue color reaction was measured
at 652 nm on a plate reader. In another set of experiment, similar immunoassay were carried out
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using increasing number of lung carcinoma cells (1500 to 6000 cells) keeping the concentration
of folate-cerium oxide constant (5.0 μM)

3.7 Conclusions:
In conclusion, we report that ceria nanoparticles possess unique oxidase-like activity, as they can
facilitate the fast oxidation of organic dyes and small molecules in slightly acidic conditions
without the need of hydrogen peroxide. When compared to other systems that require peroxides
or proteins (such as oxidases and peroxidases), our polymer-coated nanoceria is a more robust
and water-soluble redox nanocatalyst, as it is not susceptible to denaturation or decomposition.
Furthermore, conjugation with targeting ligands makes nanoceria an effective nanocatalyst and
detection tool in immunoassays. Taken together, these results demonstrate that this unique
aqueous oxidase-like activity of nanoceria can be used in a wide range of new potential
applications in biotechnology, environmental chemistry, and medicine.
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CHAPTER 4: CELLULAR UPTAKE STUDIES USING FLUOSCENTLY
LABELED CERIUM OXIDE NANOPARTICLES HAVING DIFFERENT
SURFACE CHARGE AND THEIR CORRESPONDING CYTOTOXICITY

4.1 Introduction:
Nanomaterials with unique magnetic, luminescent and catalytic properties are being engineered
for a wide range of biomedical applications ranging from imaging, diagnostics and treatment.
However, nanomaterials greatest strength, which relies primarily on the enhanced physical and
chemical characteristics that mater, exhibits at this scale, has the potential to be its greatest
liability. Potentially harmful interactions can occur between nanomaterials and living systems,
including humans. For that reason, nanomaterials must be engineered from nontoxic,
biocompatible and biodegradable components or components that have minimal and in some
cases beneficial properties. An inflammatory response is a parameter that is often investigated to
assess the effect that nanomaterials have with living systems. Exposure of titanium oxide
nanoparticles to rodents results in airway inflammation and interstitial fibrosis.53-57 Similarly,
carbon nanotubes, quantum dots, buckyballs, and silver nanoparticles are known inducer of proinflammatory response in animals.58
Cerium oxide nanoparticles are unique because they exhibit anti-inflammatory properties,
scavenging reactive oxygen species, mimic superoxide dismutase activity, and preventing cardio
vascular myopathy.11-13 As discussed in previous chapters, nanoceria displays optimal
antioxidant properties at physiological pH, whereas it behaves as an oxidant at acidic pH. This
selective behavior of nanoceria could have important implications in understanding why
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nanoceria gives selective cytoprotection to normal cell but not to the cancer cell during radiation
treatment or oxidative stress.10,39 In addition, the nature of the polymer coating surrounding the
cerium oxide core could play a critical role in determining its antioxidant versus oxidant
properties. We also reasoned that the cytotoxicity of cerium oxide nanoparticles could depend
upon the localization either inside (intracellular) or outside (extracellular) the cells. If inside then
it could be depend on whether the nanoparticles are localized in subcellular organelles such
lysosomes (which are acidic) or distributed in the cytoplasm (which is at neutral pH in normal
cells). In addition, the acidic microenvironment in most tumor59 might affect the naanoceria’s
antioxidant activity sensitizing the tumor against radiation therapy.
In this work, we report the surface charge dependent cell internalization and cytotoxicity profile
of cerium oxide nanoparticles in normal versus malignant cell lines. We selected normal H9c2
cardiac myocytes and malignant A549 lung carcinoma for our studies as they exhibit different
cytoplasmic microenvironment. A549 cell lines have been reported to have upregulated
glycolysis and production of lactic acid which result in an acidic microenvironment.25,26 In
contrast, H9c2 cardiac myocytes possesses neutral microenvironment as they have normal
cellular metabolism. Results showed that nanoceria coated with a positively charged polymer
internalized in both cell lines and

localize preferentially in their lysosomes, resulting in

cytotoxicity. In contrast, nanoceria coated with a negatively charged polymer only internalized
into lung carcinoma cell lines and exhibits toxicity as they localized in lysosomes. No significant
internalization or toxicity of negatively charged nanoceria was seen in normal cells. Surprisingly,
the nanoceria coated with a neutral polymer exhibit no toxicity to the normal cells or cancer cell
line as they preferentially localize in the cytoplasm and not the lysosomes of these cell lines.
Taken together, our results suggest that the internalization and subcellular localization of
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polymer coated cerium oxide nanoparticles plays a critical role in their toxicity profile.
Furthermore, these results suggest that the surface coating of nanoceria can be engineered to
modulate its differential cytotoxicity behavior in cancer versus normal cells.

4.2 Synthesis and characterization of polymeric DiI labeled cerium oxide nanoparticles:
For our studies, we first synthesized polymer coated cerium oxide nanoparticles of various
surface changes. To accomplish this, we coated nanoceria with polyacrylic acid (PAA),
aminated-PAA, or dextran (Figure 4.1). These diverse coatings introduce different surface charge
to the nanoparticles (-ve, +ve and neutral) which was corroborated by zeta potential
measurements (Figure 4.2a). FT-IR spectrum of these nanoparticles further confirmed their
surface functionality (Figure 4.2b) and dynamic light scattering studies revealed stable and
monodisperse nanoparticle preparations within range of 5 to 15 nm (Figure 4.2c). Moreover,
transmission electron microscopy (TEM) data showed that although the synthesized
nanoparticles have different polymer coating, they possess same nanocrystal core size of ~3 to
4nm which rule out the possibility that nanocrystal core size may be affect nanoceria cellular
interactions (Figure 4.2d).
To be able to track the localization of the nanoceria within the cell, we labeled the nanoparticles
by encapsulating a hydrophobic cyanine dye (DiI) into the available hydrophobic microdomains
inside the polymer coatings (PAA and Dextran) of cerium oxide nanoparticles following a
solvent diffusion method previously reported to label PAA and dextran coated iron oxide
nanoparticles (Figure 4.1).60 This approach to introduce a fluorescent multimodality to polymer
coated cerium oxide nanoparticles has the unique advantage that it does not compromises the
solubility of the nanoparticles in aqueous media or reduces the number of available functional
groups on the nanoparticle surface. We selected DiI since it possesses a high extinction
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coefficient, high stability (resistance to quenching) under confocal microscopy, and is widely
employed in the biomedical field for cell labeling.61 Successful encapsulation of DiI into cerium
oxide nanoparticles was confirmed by observing a in the emission spectra of the encapsulated
DiI (584 nm) compared to free DiI (592) (Figure 4.2e). These DiI encapsulated nanoparticles
display good aqueous stability over long periods of time without significant release of the dye in
aqueous medium.

4.3 Differential Cellular Interaction of Polymeric Cerium Oxide Nanoparticles with
different Surface Charge:
Confocal microscopy was carried out to study the cellular uptake and intracellular distribution of
DiI labeled cerium oxide nanoparticles. In these experiments, PAA (-), aminated PAA (+), and
dextran (neutral) coated nanoceria (1.0 mM) were incubated with A549 lung carcinoma and
H9c2 cardiomyocytes to assess their charge dependent internalization, localization and toxicity
profile. First, and to rule out the possibility of potential artifacts due to fixation, live cell imaging
after incubation PAA, dextran and aminated PAA nanoceria was carried out (Figure 4.3). Figure
4.4 shows the difference in the behavior of differently charged nanoparticles. Results show that
aminated nanoparticles bearing positive charge were internalized by both cell lines at 37 ◦C and
exhibits a more punctuate type of internalization suggesting an endosomal uptake and lysosomal
localization (Figure 4.4a and 4.4d). Surprisingly, negatively charged carboxylated nanoparticles
were uptaken by the malignant lung carcinoma cell line (A-549) but not by normal cardiac
myocytes (H9c2) (Figure 4.4b and 4.4e). In the malignant A549 cells, a lower degree of
internalization of the negatively charged nanoceria (PAA coated) is observed compared to the
positively charged (aminated PAA coated) nanoceria; however their internalization results in a
more punctuated localization of the nanoparticles suggesting that in this cell line more of the
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negatively charged carboxylated nanoparticles localized into the endosome. In contrast, neutral
dextran nanoceria internalized in both cell lines judged by the presence of a diffuse intracellular
fluorescence pattern (Figure 4.4c and 4.4f), suggesting that these nanoparticles are mostly
internalized into cytosol with a very less fraction confined to endosomal compartment. Taken
together, the above results points to the fact that the surface chemistries on polymer coated
nanoceria surface dictate their differential internalization and localization in malignant versus
normal cells.
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Figure 4-1 Schematic representation of the synthesis of surface functionalized cerium oxide nanoparticles and dye encapsulation.
Cerium oxide nanoparticles with different surface charge were synthesized using water based wet chemical method. Carbodiimide
chemistry was employed to modify the surface of the carboxylated nanoceria. DiI was encapsulated using modified solvent diffusion
method
53

Figure 4-2 Characterization of cerium oxide nanoparticles. (a) Zeta potential measurement of cerium oxide nanoparticle with different
surface functional group (negative, neutral and positive), (b) FT-IR spectrum confirming the amination of PAA-coated cerium oxide
nanoparticles, characteristics peak are shown (c) Nanocrystal core size calculated from the TEM images, and (d) Fluorescence
emission spectra of the DiI encapsulated nanoceria and that of free dye in solution.
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Figure 4-3: Real time live cell confocal imaging. Cationic polymeric nanoceria is being uptaken
in real time by lung carcinoma which shows the internalization is not due the artifacts introduced
by fixation procedure. Similar results were obtained with anionic polymeric, neutral nanoceria,
and also with cardiac myocytes.

Figure 4-4. Uptake of cerium oxide nanoparticles. Confocal microscopy show that aminated
nanoceria (+ve) is being uptaken by both cell lines lung carcinoma and cardiac myocytes while
carboxylated nanoceria (-ve) are being uptaken only by lung carcinoma cell lines. Positive
nanoparticles internalize more and seem to be localized into particular cell organelle such as
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lysosomes. Negative nanoparticles show less internalization but surprisingly mostly into
lysosmes. While neutral particles exhibit more diffuse kind of internalization and all over the
cytoplasm.

4.4 Mechanism of Cellular Uptake (Active Endocytic Process Blockage):
To further explore the mechanism of cellular internalization and to verify if an endocytic
pathway is responsible for the internalization of polymer coated nanoceria, we performed
experiments at 4◦C or in the presence of 2-deoxyglucose or sodium azide, known inhibitors of
the endocytic pathway. At 4◦C active internalization of molecule by an endocytic/pinocytic
mechanism is blocked.62 After incubating cells with the various DiI labeled nanoceria
preparations at 4◦C, we observed very negligible nanoparticle internalization (Figure 4.5a, 4.5b
and 4.5c).

None of the polymer coated nanoceria entered either of the cell lines studies

suggesting endocytosis as a possible mechanism of internalization in all cases. Experiments
performed in the presence of inhibitors at 37◦C confirm our results (Figure 4.5d, 4.5e and 4.5f).
Both cell lines incubated with nanoparticles in presence of inhibitors did not show any detectable
internalized DiI labeled polymeric nanoceria as expected.

These results confirm that our

polymeric coated nanoceria were actively uptaken by an endocytic process by both lung
carcinoma and cardiac myocytes.
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Figure 4-5. Uptake studies where active internalization processes were blocked (Determination
of internalization mechanism). No internalization of aminated or carboxylated nanoparticle is
seen in either of the cell line in presence of inhibitors, 2-deoxyglucose and sodium-azide which
blocks active internalization. Similarly, internalization of nanoparticles is abrogated at 4 ○C.
These results suggest that the uptake of nanoparticles is mediated by endocytosis since endocytic
processes are inhibited by both inhibitors and at 4 ○C
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4.5 Intracellular Distribution of Polymeric Cerium Oxide Nanoparticles (Lysosomal
Staining or co-localization studies):
To corroborate that some of the polymer coated nanoceria preparations localize to the endosomal
compartment after internalization, we treated the cells for 20 minutes with Lysotracker, a
lysosome specific dye, after incubation for 3 hours with the various nanoceria preparations.
Lysotracker is a green fluorescent dye that stains lysosomes (acidic) compartment of cells with
excitation/emission spectra at 504/511 nm.63 Co-localization was performed to see if internalized
nanoceria DiI (red) and lysosomes (lysotracker, green) overlap. Experiments showed that coincubation of DiI label aminated-PAA coated nanoceria and lysotracker in A549 lung carcinoma
cells results in co-localization of both the lysotracker and DiI label nanoceria by confocal
microscopy (Figure 4.6a, 4.6b and 4.6c). In the case of H9c2 cardiac myocytes, a different
distribution of lysotracker and DiI label nanoceria was observed which suggests that
nanoparticles are distributed into both cytosolic and lysosomal compartments of the cell (Figure
4.7a, 4.7b and 4.7c). In contrast, even though less internalization of carboxylated-nanoceria is
observed in A549 lung carcinoma, the internalized nanoparticles co-localize mostly with the
lysotracker dye, indicating mostly lysosomal localization and no cytoplasm localization (4.6d,
4.6e and 4.6f). Meanwhile, when the dextran coated nanoceria was used instead, a diffuse
distribution of internalized nanoparticle (DiI signal) was observed with very less co-localization
with the lysotracker signal in both cell lines (Figure 4.6g, 4.6h, 4.6i, 4.7d, 4.7e and 4.7f). This
indicates that the dextran coated nanoceria localizes mainly to the cytosol. These results suggest
that engineered ceria nanoparticles show different intracellular distribution into both cancer and
normal cell lines depending upon surface charge.
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Figure 4-6. Nanoparticles cell localization, lysosomal staining (Lung carcinoma). Upon
internalization nanoparticles fluorescently labeled DiI were found in colocalized into lysosomes.
Most of the internalized nanoparticles were co-localized with lysotracker (overlay). Dextran
nanoceria exhibits less co-localization with lysotracker.
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Figure 4-7. Nanoparticles cell localization, lysosomal staining (Cardiac myocytes). Aminated
nanoceria (red dye) were found to co-localize less with lysotracker in normal cell line compared
to lung carcinoma. Also, dextran-nanoceria shows even less lysotracker co-localization compare
to aminated nanoceria. However most the nanoparticles in both cases were found in the
cytoplasm

4.6 Intracellular Distribution Dependent Cytotoxicity of Polymeric Cerium Oxide
Nanoparticles:
We have shown in earlier sections that different surface charge nanoceria vary in their cellular
interaction with the normal and cancer cell lines. Nanoceria also exhibits different sub-cellular
localization into cytoplasm and lysosomes. In order to see if nanoceria sub-cellular distribution
(lysosomal or cytoplasm) can have any effect towards nanoceria cytotoxic behavior, cytotoxicity
(MTT) assay were performed. Interestingly, we found that the nanoparticles which were
internalized by the cell and were entrapped into lysosomes such as aminated (lung carcinoma and
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cardiac myocytes) and carboxylated (lung carcinoma) showed toxicity to both lung carcinoma
and cardiac myocytes (Figure 4.8a and 4.8b) Aminated nanoparticles were more toxic to lung
carcinoma and cardiac myocytes since they were found significantly inside the lysosome upon
internalization. Carboxylated nanoparticles were toxic only to lung carcinoma but less compare
to aminated given that they are less internalized into lysosomes. While dextran (neutral)
nanoparticles did not show any toxicity to either of cell lines since they were found into
lysosomes in significantly low amount. Similar experiments were carried out in presence of
inhibitors (2-deoxy glucose and sodium azide) and as expected no cytotoxicity was observed
because inhibitors block the uptake of nanoparticles (Figure 4.9a and 4.9b). Hence, these results
demonstrate that localization of nanoceria into lysosomes (acidic cell compartment) as opposed
to localization into cytoplasm leads to its cytotoxicity.

Figure 4-8. Cytotoxicity of cerium oxide nanoparticles. Graph shows that aminated nanoparticles
are more cytotoxic to both cell lines while carboxylated nanoparticles are cytotoxic to only lung
carcinoma not to cardiac myocytes. However, dextran nanoceria don’t show any toxicity to
either of cell lines
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Figure 4-9. Cytotoxicity of cerium oxide nanoparticles in presence of inhibitors showing no
toxicity.

4.7 Comparison with iron oxide nanoparticles:
The polymer coated iron oxide nanoparticles has been well established for various in-vitro and in
vitro applications such as MRI contrast agents, and drug delivery vehicle.64-67 These reports
demonstrate that polymeric iron oxide nanoparticles are non-toxic to living systems; in fact they
are currently used in clinic to image liver metathesis and metastatic lymph nodes.68 To rule out
the possibility that the toxicity profile observed with the studied polymer coated nanoceria is due
to the nature of the polymer coating, we performed experiments with iron oxide nanoparticles
coated with PAA, Aminated PAA or dextran coated iron oxide nanoparticles. Confocal
microscopy studies indicate that aminated-iron oxide nanoceria was being uptaken by lung
carcinoma as well as cardiac myocytes (Figure 4.10a and 4.10c). In contrast, carboxylated iron
oxide nanoparticles didn’t show any detectable signal under confocal microscopy in either of cell
lines (Figure 4.10b and 4.10d). In addition to these, very disperse kind of internalization is seen
as compare to the punctuate kind in case of polymeric nanoceria. These results rule out the
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possible localization of polymeric iron oxide into lysosomes. Next, MTT assay were carried out
with polymeric iron oxide nanoparticles to confirm any toxicity. As expected, polymeric iron
oxide nanoparticles didn’t show any toxicity even when they are internalized by both normal and
cancer cell lines (Figure 4.11a and 4.11b). This behavior for iron oxide is expected as iron oxide
does not possess oxidant activity at low pH and clearly indicate that it is the intrinsic oxidase-like
behavior of cerium oxide nanoparticles which is responsible for its cytotoxicity, especially when
they localized into the acidic cell compartment such as lysosomes.

Figure 4-10. Uptake of polyacrylic acid coated iron oxide nanoparticles. Confocal showed that
only aminated-PAA iron oxide nanoparticles were uptaken by lung carcinoma and cardiac
myocytes.
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a)

b)

Figure 4-11. Cytotoxicity of Iron oxide nanoparticles demonstrating that polymeric iron oxide
nanoparticles are not toxic to any of the cancer or normal cell lines.

4.8 Experimental section:
4.8.1 Synthesis of PAA-coated ceria
Preparation of PAA-coated ceria involves the use of cerium (III) nitrate and polyacryclic acid
(PAA). 1M cerium (III) nitrate (Aldrich, 99%) solution (2.17 g in 5.0 ml of water) was mixed
with 0.5 mM solution of PAA (Sigma). Under continuous stirring, the mixture was added drop
wise to 30.0 ml ammonium hydroxide (Sigma Aldrich, 30%) solution. Afterwards mixture
stirred continuously for 24 h, at this point the solution has changed from a light yellow to a deep
brown color. Next, preparation centrifuged at 4000 rpm for two 30-minute cycles to settle down
any debris and large particles. Centrifuged solution was then purified from free PAA by
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ultrafiltration using 30K molecular weight cut-off Amicon filter (Millipore Inc.). Dextran coated
nanoceria was prepared in similar manner except dextran was used instead of PAA.

4.8.2 Amination of PAA-coated ceria
For amination, 5.0 mL of PAA-coated ceria (0.060mg/mL) was treated with EDC (30.0 mg in
500 uL of 0.1 M MES buffer pH 6.0) for one minute and reacted with n-hydroxy succinamide
(22.0 mg in 500 uL of 0.1 M MES buffer pH 6.0) for 3 minutes. To the solution mixture,
ethylene diamine (EDA) (20 mg in DMSO) was added in drop wise and the solution mixture was
stirred for 3 hrs. Then mixture was purified to get rid of excess EDA using the amicon 30K
membrane.

4.8.3 DiI encapsulation in PAA-coated ceria and aminated- PAA-coated ceria
In order to encapsulate DiI in PAA-coated ceria and aminated preparation, to 4.0 mL of both
PAA-coated cerium preparation (0.060mg/mL) 200.0 uL of DiI (6.0 uL of DiI solution (1.0 mM)
in 1.2 mL of DMSO) was added in dropwise on votex (1000 rpm) at room temperature.
Afterwards, preparation was dialyzed in water to remove any free DiI and finally dialyzed
overnight in phosphate buffer saline (PBS) to get final preparation in PBS.

4.8.4 Characterization
Dynamic light scattering (DLS) studies were performed by analyzing dilute solutions of all
preparation using a PDDLS/Cool Batch 40T, PD2000 DDLS. Fluorescence spectroscopy studies
were done using a Nanolog HORIBA JOBIN YVON spectrometer. Zeta potential measurements
were performed using Malvern Zetasizer using disposable zeta cell. FT-IR experiments were
performed in a Perkin Elmer Spectrum 100 FT-IR spectrometer using vacuum dried sample.
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4.8.5 Cell Studies
Cardiomyocytes (H9c2) and lung cancer (A-549) were obtained from ATCC, USA.
Cardiomyocytes cells were grown in Eagle’s Minimal Essential medium supplemented with fetal
bovine serum (10%), sodium pyruvate, L-glutamine, penicillin, streptomycin, amphotericin B
and non-essential amino acids. Lung cancer cells were grown in Kaighn’s modification of Ham’s
F12 medium (F12K) supplemented with fetal bovine serum, L-glutamine, streptomycin,
amphotericin B and sodium bicarbonate. All cell lines were maintained at 37 ºC, 5% CO2 in a
humidified incubator.

4.8.6 Cellular Uptake of Nanoparticles
Cells were seeded in petridishes and incubated with Carboxylated-DiI-nanoceria and AminatedDiI-nanoceria for three 3 hrs. Then cells were washed with PBS buffer and fixed using 10%
formalin in PBS buffer. Afterwards, cells were incubated with the DAPI for 10 minutes. Then
again washed and visualized under the confocal microscope

4.8.7 Inhibition of Uptake or Inhibitors
a) For inhibitors studies cells were treated with the inhibitors, sodium-azide (10 mM) & 2dexoyglucose (50 mM) for 30 minutes. Afterwards, cells were incubated with Carboxylated-DiInanoceria and Aminated-DiI-nanoceria particles for three hours. Fixation and subsequent
treatment with DAPI were similar to the internalization. b) A similar experiment was done
except instead of treating cells with inhibitors cells were allowed to incubate with nanoparticles
at 4 C.
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4.8.8 Lysosome Labeling or Lysotracker Staining
After treatment with the nanoparticles for three hours cells were washed and incubated for 20
minutes with lysotracker (35 nM). Fixation and subsequent treatment with DAPI were similar to
the previous experiment.

4.8.9 Cell viability Assays
Cells were seeded in 96-well plates at a density of 3,000 cells per well and incubated with (1.0
mM) carboxylated and aminated-nanoceria for 3 hrs. Then, 0.5 mM of MTT (3-(4,5Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) (Sigma,USA) was added followed by
incubation for 24 h. After 24 h, the resulting crystals were dissolved in 20 μL of isopropanol and
the absorbance at 570 nm was recorded using a plate reader (Bio- TEK, Synergy HT
Multidetection Microplate reader). These experiments were performed in triplicates.

4.9 Conclusions:
The toxicity of nanomaterials depends on various factor including the nature of the nanoparticle
core, mode of synthesis, chemical composition (purity, crystallinity), surface structure (surface
reactivity, surface groups, inorganic or organic coatings), solubility, shape, and aggregation etc.
Not much research has been done in the effect of polymeric surface coating and surface charge
on the uptake, localization and toxicity of nanomaterials. This is highly important as some
nanomaterials, such as cerium oxide, display either a beneficial (antioxidant) or toxic (oxidant)
effect depending on the pH of the surrounding environment. We showed that the polymer coated
nanoceria display different level of toxicity depending upon a surface charged dependent cellular
uptake and subcellular localization. We found that when polymer coated nanoceria internalize
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and localize mainly in the lysosomes it become toxic due to the acidic nature of this organelle;
whereas, when it localizes mainly in the cytoplasm, less toxicity is observed. As expected,
polymer coated nanoceria is not toxic when it does not internalize into the cell. The
internalization and eventual localization of the nanoparticles within the cell depends greatly on
the surface charge of the polymeric coating on nanoceria and the type of cell used (malignant
versus normal). Here, cationic polymer coated nanoceria has been more toxic as these
nanoparticles were uptaken by both cell lines (cancer and normal cell lines), and they localize
mostly into the lysosomes. In fact, cationic polymer coated nanoceria are comparatively more
toxic to lung carcinoma contrary to cardiac myocytes. Previously, it has been shown that cationic
nanoparticles enters cell either by inducing transient holes/poration into cell membranes, a
process associated with cytotoxicity.70 But cationic polymer coated nanoceria still exhibit
toxicity although uptaken by endocytic mechanism. This proves the fact that it is the nanoceria’s
intrinsic oxidase-like property which is responsible for cytotoxic property. Anionic polymer
coated nanoceria were internalized into lung carcinoma cells and not in cardiac myocytes.
Although a lower degree of internalization was observed with the anionic nanoparticles as
compared to their cationic counterparts, almost all of them were found to be present in the
lysosomal compartments of lung carcinoma. This explains why anionic polymer coated
nanoceria elicits cytotoxicity to lung carcinoma while it is non-toxic to cardiac myocytes.
Alteration in surface charge to neutral (dextran coated nanoceria) leds to drastic change in
cellular penetration/interaction of neutral polymer coated cerium oxide nanoparticles. A very
disperse and diffuse kind of intracellular distribution was seen throughout both cell lines (cancer
and normal) with very few nanoparticles localized into lysosomes, which explains the minimal
toxicity of these nanoparticles.
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In summary, we believe that highlighting the role of surface charge and cell type in cellular
interaction of polymer coated nanoceria will shed new light on understanding of molecular
interactions/localization that leads to toxicity of nanoceria.
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70

Figure 4-12. Schematic representation of nanoparticles cell internalization, localization and
hypothesized mechanism for their toxicity. As shown in schematic aminated nanoceria are found
more internalized and entrapped mostly in lyosome in lung carcinoma. pH of microenvironment
of lung carcinoma and lyosome is acidic enough for nanoceria to exhibit oxidase like activity.
This might be the reason why aminated nanoceria are more cyototoxic compare to carboxylated
which are less toxic to lung carcinoma. However, aminated nanoceria are also toxic to cardiac
myocytes since they are found both in lysosomes and cytoplasm in cardiac myocytes.
Carboxylated nanoparticles don’t show any internalization in cardiac myocytes hence any
toxicity. Dextran nanoceria shows very diffuse kind of internalization and are less confined to
lysosomes which do not alter nanoceria property and hence dextran nanoparticles not toxic to
either of cell lines.
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CHAPTER 5: CONCLUSIONS
Taken together, our results suggest that we have successfully synthesized a highly stable and
water soluble polymer coated cerium oxide nanoparticles preparation that retains the unique
antioxidant/radical scavenging properties of uncoated cerium oxide nanoparticles. Our aqueous
nanoceria preparation was synthesized using non-toxic materials and without the use of
surfactants or high temperature methods etc. Polymer coated cerium oxide nanoparticles shown
great stability in physiological solution over long periods of time without any agglomeration,
precipitation or loss of activity. Taking advantages of their enhanced aqueous stability we
performed a series of experiments, not possible with previously synthesized methods. First, we
performed pH-dependent experiments that showed an interesting phenomenon that nanoceria do
not exhibits reversibility between Ce+3 and Ce+4 states at pH 4.0 while being regenerative at
physiological pH 7.0. This observation could explain why nanoceria protects the normal cells
(acting as antioxidant) and do not protect cancer cell (acting as oxidant). Second, we established
the pH-modulated dual antioxidant/oxidant behavior of cerium oxide nanoparticles. We found
that nanoceria exhibit an oxidase-like activity, by studying the oxidation of chromogenic dyes
such TMB and AzBTS without the need of hydrogen peroxide at low pH. Third, internalization
studies were carried out to see if the observed dual antioxidant/oxidase-like property can have
any effect on cytotoxic behavior of nanoceria when it interact or penetrate the cell. The
internalization experiments demonstrated that the polymeric cerium oxide nanoparticles do
behaves differently when inside or outside the cells. They are non-toxic when they are outside.
When they are inside, their localization in different cell organelles such lysosomes or cytoplasm
dictate their cytotoxicity. Results demonstrated that localization of nanoceria into lysosomes
72

(acidic cell compartment) as opposed to localization into cytoplasm is responsible for their
cytotoxicity.
In summary, we found up with some of the new interesting properties of cerium oxide
nanoparticles yet not discovered before such as oxidase-like behavior or pH-triggered dual
antioxidant/oxidant behavior. All findings made in this dissertation open up new vistas for
cerium oxide nanoparticles applications that include the development of antioxidant and antiinflammatory coatings in prosthetic devices and tissue engineering, and their use as building
blocks in supramolecular materials. Moreover, oxidase-like behavior can be employed to design
as more robust and water-soluble redox nanocatalyst, as it is not susceptible to denaturation or
decomposition. This unique aqueous oxidase-like activity of nanoceria can also be used in a wide
range of new potential applications in biotechnology, environmental chemistry, and medicine.
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